AI for Life 2024, by Artefact

NS

Nicolas Stalder

Debiopharm

Senior Investment Associate

All Sessions

Personalized cancer treatment: From biomarkers to targeted therapies

Digital Health Strategic Alliance Management

Medical Imaging Data Scientist

Pr Olivier Michielin, MD-PhD

Hôpitaux Universitaire de Genève

Chair, Department of Oncology & Head of Precision Oncology Service

Claudia Scheckel

Co-founder & CEO

Nicolas Stalder

Senior Investment Associate

ML & Software Engineering Director

Loading